Skip to main content

News Archive

News Archive - Susanne Clara Bard

No Shortage of Solutions

February 7, 2025

Pharmacists at UC San Diego are working hard to help with the nationwide drug shortage crisis.

How Healthy Stem Cells Turn Into Oral Cancer

February 4, 2025

UC San Diego researchers have identified the molecular and cellular mechanisms that transform healthy stem cells into oral cancer at the earliest stages of the disease.

Enzyme Promoting Tumor Growth and Spread in Pancreatic Cancer Identified

January 2, 2025

An enzyme called MICAL2 promotes tumor growth and metastasis in the most common form of pancreatic cancer, according to a new study by UC San Diego School of Medicine researchers.

Staphylococcus Aureus Thwarts Vaccines by Turning on a Protein That Halts Immune Response

December 16, 2024

After dozens of clinical trials, there are still no effective vaccines against Staphylococcus aureus. In two new studies, scientists report that the pathogen turns on the protein interleukin 10, shutting down the protective vaccine response. But blocking the protein restores vaccine efficacy in an animal model.

Changes in Blood Cell Production Over the Lifetime Could Impact Leukemia Outcomes

December 5, 2024

The first comprehensive map of the dramatic changes that take place in the blood system over the course of the human lifetime could have implications for the treatment of acute myeloid leukemia and other blood diseases.

Cetuximab Outperforms Durvalumab in Treatment of Head and Neck Cancers

November 19, 2024

The standard treatment for head and neck cancer, cisplatin, can’t be given to some patients due to pre-existing conditions. A new study compares the efficacy of two alternatives: cetuximab, a monoclonal antibody, and durvalumab, an immune checkpoint inhibitor.

Optical Biosensor Rapidly Detects Monkeypox Virus

November 14, 2024

Researchers at UC San Diego and their colleagues have developed an optical biosensor that detects the virus that causes mpox. The technology could make diagnosis much faster and cost-effective as the disease continues to spread worldwide.

Key Pathway Leading to Neurodegeneration in Early Stages of ALS Identified

November 8, 2024

Researchers at UC San Diego identify a key pathway leading to neurodegeneration in early stages of ALS, hinting at the potential for short-circuiting the progression of the fatal disease if diagnosed early.

UC San Diego Awarded $8 Million to Uncover Genetic Foundations of Substance Use Disorders

October 28, 2024

UC San Diego has received a five-year, $8 Million grant to support a NIDA P30 Center to investigate the genetics, genomics, and epigenetics behind substance use disorders.
Category navigation with Social links